Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
JACC. Cardiovascular Interventions|October 25, 2023
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary InterventionDominick J Angiolillo, Davide Cao, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 18, 2022
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG studyGennaro Sardella, Frans J Beerkens, George Dangas, et al.
Cardiology Journal|April 20, 2018
Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpointJacek Kubica, Piotr Adamski, Przemysław Paciorek, et al.
JACC. Cardiovascular Interventions|January 16, 2022
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT SubstudyMauro Chiarito, Usman Baber, Davide Cao, et al.
The New England Journal of Medicine|September 27, 2019
Ticagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, et al.
Cardiology Journal|October 19, 2020
Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelinesJacek Kubica, Piotr Adamski, Piotr Niezgoda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 9, 2021
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT studyGeorge Dangas, Usman Baber, Samin Sharma, et al.
European Heart Journal|October 21, 2020
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick Joseph Angiolillo, et al.
Cardiology Journal|May 22, 2025
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?Jacek Kubica, Piotr Adamski, Katarzyna Buszko, et al.
JACC. Cardiovascular Interventions|October 6, 2022
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass IndexVijay Kunadian, Usman Baber, Carlo A Pivato, et al.
Pageof 9